A previous study by Duan [24] reported that calycosin, a major component of Astragali radix, ameliorates HFD-induced NAFLD by inhibiting gluconeogenesis through the modulation of Farnesoid X receptor (FXR) activation. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.